In animal experimental studies, Qiwei granules can delay the development of DKD by reducing podocyte injury and protecting renal function by upregulating the expression of nephrin[13,14] and CD2AP[15] in renal podocytes of DKD. This evidence concerns the gene CD2AP and diabetic kidney disease.